The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Fiscal Year 2024 (FY24) Toxic Exposures Clinical Trial Award (CTA) to support clinical trials focused on military-related toxic exposures. This funding opportunity aims to facilitate research that addresses the prevention, diagnosis, treatment, and underlying mechanisms of health issues stemming from such exposures, with applicants required to align their proposals with at least one FY24 Toxic Exposures Research Program (TERP) Goal and Topic Area. The initiative is crucial for advancing understanding and management of health consequences related to military service, with a total funding pool of $30 million available, including direct costs capped at $1.5 million for single Principal Investigator (PI) projects and $2.5 million for partnering PI applications. Key deadlines include a pre-application due by August 13, 2024, and a full application by November 7, 2024; interested parties can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.